The human prostate and seminal vesicles are both androgen-dependent sex accessory organs. Their growth behavior, response to hormone manipulation, susceptibility to benign and malignant processes and sex accessory functions, however, differ greatly. The growth behavior of most tissues correlates well with the cell turnover rate of that tissue. Therefore, we compared the cell turnover of normal human prostate and seminal vesicles.
Introduction
The human prostate and seminal vesicles and are both sex accessory organs with androgen-dependent morphogenesis, growth and secretion. Moreover, they are in close anatominal proximity and thus share the same blood supply, innervation and exposure to carcinogens. 1 Prostate cancer is the most common noncutaneous malignant tumor in men today. 2 In sharp contrast, the seminal vesicles rarely develop malignant tumors. Only 53 documented cases of seminal vesicle adenocarcinomas have been reported in the literature. 3 ± 5 The reason why the prostate is the only sex accessory organ that manifests such a high rate of malignant changes remain unclear. Moreover, benign prostatic hyperplasia (BPH) is the most frequent benign disease in men, whereas benign tumors of the seminal vesicles have rarely been reported.
Organ growth, both benign and maligant, is highly dependent on the cell turnover of the tissue. 6 Cell turnover represents a balance between cell proliferation and cell death. Programmed cell death is called apoptosis. 7 Suppression of apoptosis is known to be an important step in carcinogenesis. 8, 9 Moreover, the cell proliferation rate can also be associated with the malignant transformation of a tissue. 10 Cell turnover is regulated by several growth factors, including bcl-2 and transforming growth factor (TGF) b. 11, 12 Although the apoptotic rates and proliferation rates of normal and malignant prostatic tissue have been studied extensively, no study has investigated the cell turnover in human seminal vesicles. Differences in cell turnover may play a role in the vastly different incidence of malignant transformation between these two organs. Thus, we determined the proliferation rate, apoptotic index and the expression of bcl-2 and TGF b in human prostate and seminal vesicle tissue.
Materials and methods
For immunohistochemical staining, 20 individual tissue specimens each of histologically con®rmed benign prostatic tissue and normal seminal vesicle were evaluated. The prostatic tissue was isolated from cystoprostatectomy specimens from men undergoing radical cystectomy for muscle invasive bladder cancer. The seminal vesicle tissue derived from nine patients undergoing radical cystectomy and from 11 prostatectomy specimens from men with clincally localized prostate cancer undergoing radical prostatectomy. In all specimens, histologic evidence of cancer was excluded by a uropathologist. The mean age of the men from whom the prostate samples were obtained was 59.6 y (range 46 ± 73 y), the mean age of the men from whom the seminal vesicle tissue was taken was 58.4 y (range 45 ± 74 y).
For all immunohistochemical staining procedures, formalin-®xed, paraf®n-embedded tissue was used. The tissue was sectioned, deparaf®nized in xylene and rehydrated. The apoptotic rate was determined with the TUNEL (terminal deoxynucleotidyl transferase-mediated hapten-labeled deoxy-uracil triphosphate nick end labeling) 13 technique. Following rehydration, tissue sections were immersed in 20 mg/ml of proteinase K for 15 min to digest the protein from the DNA. After three rinses in PBS (phosphate-buffered saline), the slides were immersed in a solution of 0.3% hydrogen peroxide in 50% methanol for 20 min to inactivate endogeneous peroxidase. After washing in distilled water three times, the tissue was immersed in TDT (terminal dexoxynucleotidyl transferase) buffer (30 mM Trizma base, pH 7.2, 140 mM natrium-cacodylate, 1 mM cobaltchloride), 300 units/ml, for 5 min. Biotinylated dUTP (deoxy-uracil-triphosphate) was placed on each slide and was incubated at 37 C for 60 min. In the next step, the tissue was washed with TDT buffer and soaked in 1 TB (tris buffered) buffer for 15 min to terminate the reaction. After three washes with PBS, the tissue was incubated with diluted streptavidin peroxidase (1 : 10) for 30 min at 37 C. After three more rinses with PBS, the slides were stained with DAB (diaminobenzidine-tegrahydrochloride) for up to 10 min and were countersigned with ethyl green. Staining was recorded as the number of positive cells per 1000 counted cells. 2000 cells were manually counted for each case.
For the detection of proliferating cells, a monoclonal, mouse MIB 1 antibody (AMAC, Westbrook, Maine, USA) were used. After deparaf®nization, the antigen was enhanced by treating the slides with sodium citrate buffer and heating in the microwave at 100 C twice. The antibody was used in a 1 : 100 dilution. The tissue was incubated at 37 C for 60 min. The streptavidin peroxidase technique and DAB staining were used as described above. The proliferative and the apoptotic indices were calculated as the percentage of positively stained cells in relation to the number of cells counted. 14 For immunostaining for TGF b and bcl-2, a polyclonal rabbit anti-TGF b 1 antibody (Santa Cruz Biotechnology, USA) and a monoclonal mouse anti-bcl-2 antibody (DAKO, Glostrup, Denmark) were used. The tissue were deparaf®nized, rehydrated and incubated with hydrogen peroxide as described above. The streptavidin peroxidase technique and DAB staining were used as described above. Counterstaining for TGF b 1 was performed with ethyl green and with hematoxilin for bcl-2.
Results

Apoptotic index and proliferative index
Apoptotic fragments of the DNA could be detected with the TUNEL technique reliably and easily. Typically, nuclear staining was present, but in some cases, a light staining of the cytoplasm was detected as well. Characteristically, single apoptotic cells were found among normal prostatic ( Figure 1 ) and seminal vesicle cells. Apoptotic cells were predominantly found in the secretory epithelial cells and less frequently within the basal cell population, whereas TUNEL staining of stromal cells was not observed in either tissue. Concerning the localization of apoptotic cells, no difference between prostate and seminal vesicles could be found. The rate of apoptotic cells in the seminal vesicles, however, was extremely low and in some specimens, apoptosis could not be detected at all. The mean number of apoptotic and proliferating cells (Figure 2 ) is seen in Table 1 . Apoptotic rates and proliferative rates of seminal vesicles and prostate were signi®cantly different (P`0.003 and P`0.002). In summary, an equilibrium between proliferation and apoptosis exists in both tissues. The cell turnover in the prostate, however, is much higher than in the seminal vesicles, where hardly any cell turnover could be detected. 
The expression of transforming growth factor (TGF) b 1 in prostate tissue was limited to the cytoplasm of the glandular epithelium. The immunoreactivity was only minimal and was not found to be evenly spread within the slides, but foci of stained cells were observed. In 75% of the specimens, no immunostaining for TGF b 1 was detected at all. TGF b 1 immunoreactivity was not found in any of the seminal vesicle specimens.
Bcl-2 expression was detected in seminal vesicles as well as in prostate tissue. Staining was found in epithelial cells and basal cells, bcl-2 staining in stromal cells was not observed.
Only a small percentage of the prostates (20%) demonstrated bcl-2 staining. Staining in these specimens was weak and limited to a few cells. The incidence of the bcl-2 expression was higher in the seminal vesicles. Moreover, the bcl-2 expression in the seminal vesicles was more pronounced than in the prostate. Of the seminal vesicle samples 55% demonstrated bcl-2 staining. The incidences of bcl-2 and TGF b staining in prostate and seminal vesicle tissue are shown in Table 2 .
Discussion
This is the ®rst study to compare the cell kinetics of the epithelial cells of the prostate and the seminal vesicles by immunohistochemical techniques. Both organs are androgen dependent, male accessory sex organs which exhibit completely different growth patterns. A growth imbalance in favor of cell proliferation has been proposed to be related to benign prostatic hyperplasia, 15 and in the development of malignant tumors. 16 Thus, the comparison of the cell kinetics of these tissues may aid in understanding the different proliferative pattern of these organs. In our study, the proliferative index of the normal prostatic tissue was 0.77 and the apoptotic index was 0.73, respectively. The cell kinetic measurement of normal prostatic tissue in our study was consistent with previous studies, reporting apoptotic rates ranging from 0.1 to 1.9 and proliferative indexes between 0.1 and 1.1. 14,15,17 ± 19 These low proliferative and apoptotic activities result in a steady state without net growth or regression of the gland. The cell kinetic measurements of the prostate are well documented, yet no report the authors are aware of is available describing the cell turnover in human seminal vesicles. Our study is the ®rst to show that the proliferative index in the seminal vesicle is signi®cantly lower (0.02) than in the prostate. The apoptotic index in the seminal vesicles is equally low (0.02). Thus, proliferation and apoptosis in the seminal vesicles are balanced at an extremely low level. The proliferative and apoptotic activity in the prostate is signi®cantly higher than the cell turnover in the seminal vesicles.
Apoptosis and proliferation in the prostate and seminal vesicles are in¯uenced by androgens. In animal experiments, androgen withdrawal in rats led to a marked decrease of proliferation and to a dramatic increase in apoptosis in the prostate, resulting in an apoptotic rate of 70% seven days after castration. 20 Macroscopically, involution of the prostatic gland could be observed. The specimens in our study derived from otherwise healthy men with similar ages without any form of hormonal manipulation. Thus, clinically signi®cant differences in the androgen levels of the patients are highly improbable, and therefore androgens appear not to play a major role in the etiology of the observed differences in the cell kinetics of the normal human prostate and seminal vesicles.
Bcl-2 and TGF b are known to be involved in the regulation of apoptosis and cell proliferatioin. TGF b 1 physiologically regulates apoptosis in normal prostatic tissue. 11 Furthermore, TGF b 1 seems to have a direct apoptotic effect on prostatic cells. 21 In previous reports, normal prostatic tissue demonstrated only a weak and focal expression of TGF b 1 . 12 Our study supports these ®ndings, as weak TGF b 1 expression was found in only 25% of the specimens. In seminal vesicles, no TGF b 1 expression was detectable at all within this study.
The proto-oncogen bcl-2 is an inhibitor of apoptosis in a variety of tissues. 12 Bcl-2 affects the survival of cells which have been programmed to die. This may result in an accumulation of genetic abnormalities which may affect the development and growth of cancer cells. 12, 15 In normal prostate tissue, bcl-2 expression was either undetectable 22 or only weakly stained tissue was Cell turnover in human prostate and seminal vesicle J Pannek et al observed, 15 whereas it was found to stain in prostate cancer tissue with a very high incidence. 14 In our study, only 20% of the prostate specimens showed a weak bcl-2 expression, whereas in 55% of the seminal vesicles, bcl-2 expression was observed. The differences in bcl-2 expression in seminal vesicles and prostatic tissue correlated with the apoptotic rates of these organs. The signi®cantly higher expression of bcl-2 in seminal vesicles may explain the very low apoptotic index in this tissue, whereas the lower bcl-2 expression in the prostate might account for the higher apoptotic index in this organ. Only in proliferating cells will defects in single-strand DNA develop into mutations. 23 Moreover, only dividing cells can multiply these mutations. Thus, it is suspected that a high proliferation rate correlates with an increased tumor risk. In super®cial bladder tumors, for example, cell proliferation correlates with grading and prognosis of the tumors. 10 In some tissues, however, for example the small bowel, this correlation does not exist. Therefore, this theory is not generally accepted. 24 Cells with a high proliferative index do not necessaerily have a high cancer incidence. 25 On the other hand, it is suspected that apoptosis will eliminate mutated or damaged cells from the organism and will therefore play a role in cancer prevention. 16 In this case, not just the proliferation rate, but the relation between the proliferative index and the apoptotic index will play an important role in carcinogenesis. 24 On the other hand, some studies demonstrated that the apoptosis rate was elevated in preneoplastic cells compared to normal cells from the same tissue. 26 The differences in cell turnover in prostate and seminal vesicles are unique. The small and large bowels represent another pair of organs with similar blood supply, similar exposure to carcinogens and a markedly different tumor incidence. In contrast to the prostate and seminal vesicles, the proliferation rate in the small bowel is higher than in large bowel, whereas the cancer incidence is higher in large bowel. 27 Our study demonstrated that the cell turnover in normal seminal vesicles is lower than in the prostate and therefore there is no evidence of an increased apoptotic rate as the reason for the extremely low cancer incidence of the seminal vesicles.
Conclusions
This is the ®rst study to compare the cell turnover of normal human prostate and seminal vesicles. In both tissues, apoptotic rates equal proliferation rates. The cell turnover, however, is much higher in the prostate than in the seminal vesicles. Thus, apoptosis seems to be less important for the growth regulation in the seminal vesicles.
